Why iRhythm Holdings, Inc.’s (IRTC) Stock Is Up 5.30%
As of Wednesday, August 19, iRhythm Holdings, Inc.’s IRTC share price has surged by 5.30%, which has investors questioning if this is right time to sell.Jenna Brashear
Stock Evaluator: iRhythm Holdings, Inc. (IRTC)
iRhythm Holdings, Inc. IRTC
$106.70
4.10
4.00%
October 9, 2026 4:00:00 PM
EST
Volume: 516,473
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
Commentary & Analysis
Why iRhythm Holdings, Inc.’s (IRTC) Stock Is Down 5.14%
As of Monday, August 17, iRhythm Holdings, Inc.’s IRTC share price has dipped by 5.14%, which has investors questioning if this is right time to buy.Michael Rose
Is iRhythm Holdings, Inc. (IRTC) Overvalued?
We dive into why iRhythm Holdings, Inc. (IRTC) could be considered overvalued on 2026-07-30, based on AAII’s Value Score and Grade.Jenna Brashear
Why iRhythm Holdings, Inc.’s (IRTC) Stock Is Down 5.70%
As of Friday, July 17, iRhythm Holdings, Inc.’s IRTC share price has dipped by 5.70%, which has investors questioning if this is right time to buy.Jenna Brashear
Why iRhythm Holdings, Inc.’s (IRTC) Stock Is Down 5.83%
As of Thursday, July 09, iRhythm Holdings, Inc.’s IRTC share price has dipped by 5.83%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Financial Summary
| Share Statistics | IRTC | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $3,517.2 | $385.5 | 63% |
|
| Shares Out (Mil) | 32.9 | 40.8 | 39% |
|
| Institutional Ownership | 98.6% | 83.0% | 80% |
|
| Float (Mil) | 30.3 | 35.5 | 36% |
|
| Beta | 1.32 | 0.85 | 76% |
|
| Avg Daily Volume (000s) | 464 | 321 | 56% |
|
| Price Change (52-week) |
(40.4%) | 64.6% | 24% |
|
| Growth | IRTC | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 23.0% | 11.8% | 84% |
|
| Net Income (5yr) | (0.4%) | (5.5%) | 39% |
|
| EPS (5yr) | 2.5% | 10.2% | 35 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (34.1%) | (15.5%) | 16% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 10 | 10 | 6 | |
| Current EPS | $0.047 | $0.574 | $1.282 | |
| Month Ago EPS | $0.042 | $0.585 | $1.202 | |
| # Rev Up | 0 | 0 | 2 | |
| # Rev Down | 0 | 1 | 0 | |
| Three Months Ago EPS | $0.089 | $0.117 | $1.051 | |
| Year/Year Chg | (491.7%) | (141.2%) | (276.9%) | |
| Financials | IRTC | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $825 | $155 | 47% |
|
| Net Income (TTM) (Mil) | ($14) | ($9) | 27% |
|
| EPS (TTM) | ($0.430) | ($0.400) | 29% |
|
| Operating Cash Flow (TTM) (Mil) | $86 | ($2) | 51% |
|
| Net Cash Flow (TTM) (Mil) | ($62) | $1 | 18% |
|
| Long-Term Debt (Q1) (Mil) | $710 | $27 | 62% |
|
| Enterprise Value (Q1) (Mil) | $3,740 | $418 | 58% |
|
| Valuation | IRTC | Industry Median |
Percentile (All Stocks) |
|
| P/B | 18.88 | 2.69 | 95% |
|
| P/E | na | 24.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.5 | na |
|
| Ratios | IRTC | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 71.5% | 58.5% | 82% |
|
| Net Margin | (1.7%) | (6.9%) | 29% |
|
| ROA | (1.4%) | (12.2%) | 35% |
|
| ROE | (9.6%) | (10.5%) | 28% |
|
| Liabilities to Assets | 83.0% | 47.2% | 77% |
|
| F-Score | 6 | 4 | 67% |
|
iRhythm Holdings, Inc. did not pass any screens on 10/9/2026.
